Compounds > 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea
Page last updated: 2024-08-23

1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Adenocarcinoma Of Kidney

1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea has been researched along with Adenocarcinoma Of Kidney in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bono, AV; De Pauw, M; Droz, JP; Fossa, ST; Keizer, J; Splinter, TA; Sylvester, R; Van Oosterom, AT; Verbaeys, AJ1

Other Studies

1 other study(ies) available for 1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea and Adenocarcinoma Of Kidney

ArticleYear
TCNU in advanced renal cancer. Phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:12

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Taurine

1989